EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration

Chuantao Wu iD, Jiejing Lin, Qikai Chen, Wenxue Zhao, Ichiro Kawahata iD, An Cheng iD

Cells · 2025

DOI: 10.3390/cells14191502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Chuantao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Neuroinflammatory Diseases, Fatty Acid-Binding Proteins, Neurodegenerative Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Start-up Fund from Sun Yat-sen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fatty acid-binding proteins (FABPs) represent a superfamily of intracellular lipid chaperones essential for the transport of lipids and homeostatic lipid metabolism. Although well-known for their role in systemic metabolic diseases, emerging evidence has identified brain-expressed FABPs as core players in neurodegeneration. This review focuses on brain-expressed FABPs, synthesizing recent advancements that link their role in metabolic dysregulation to neurotoxicity. We present a system that integrates these proteins within a multi-tiered complex pathobiological system that involves: an advanced glial “meta-inflammation” paradigm; a novel view on proteotoxicity via liquid–liquid phase separation (LLPS); changes in the gut–brain axis; and an involvement in the regulation of ferroptosis. Additionally, we also discuss the emerging pharmacological pipeline, highlighting notable preclinical ligands and drawing important lessons from systemic disease first-in-class-targeted FABPs. These first-in-class therapies have successfully validated this target family in systemic diseases. Finally, we explore future therapeutic strategies, where we emphasize the challenges and the precision cell-type-specific delivery approaches to harness the full therapeutic potential of these pivotal proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismNeuroinflammatory DiseasesFatty Acid-Binding ProteinsNeurodegenerative DiseasesHumansAnimalsBrain

Stichwörter der Autor:innen

FABP-targeted therapyfatty acid-binding proteins (FABPs)glial metabolismmetabolic reprogrammingneurodegenerative diseasesneuroinflammation

Substanzen

Fatty Acid-Binding Proteins

Autor:innen und Institutionen

  • School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen 518107, China.
  • Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University Graduate School of Medicine, Hikarigaoka, Fukushima 960-1295, Japan.
  • Department of Ophthalmology, School of Medicine, University of California San Francisco (UCSF), San Francisco, CA 94143, USA.

ORCID-Profile: Chuantao Wu, Ichiro Kawahata, An Cheng

Förderung

  • Start-up Fund from Sun Yat-sen University

Zitieren

APA

Wu, C., Lin, J., Chen, Q., Zhao, W., Kawahata, I., & Cheng, A. (2025). Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration. Cells. https://doi.org/10.3390/cells14191502

Vancouver

Wu C, Lin J, Chen Q, Zhao W, Kawahata I, Cheng A. Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration. Cells. 2025. doi:10.3390/cells14191502

BibTeX
@article{Wu2025,
  author = {Wu, Chuantao and Lin, Jiejing and Chen, Qikai and Zhao, Wenxue and Kawahata, Ichiro and Cheng, An},
  title = {Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14191502}
}
Kostenlos starten →